Predictors of AMD treatment response
| Data(s) |
01/11/2012
|
|---|---|
| Resumo |
A letter to the editor that refers to the following article :<div> Frank G. Holz, Winfried Amoaku, Juan Donate, Robyn H. Guymer, Ulrich Kellner, Reinier O. Schlingemann, Andreas Weichselberger, Giovanni Staurenghi, SUSTAIN Study Group. Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study<br />Ophthalmology, Volume 118, Issue 4, April 2011, Pages 663-671</div> |
| Identificador | |
| Idioma(s) |
eng |
| Publicador |
Elsevier |
| Relação |
http://dro.deakin.edu.au/eserv/DU:30061496/busija-predictorsofamd-2012.pdf http://dx.doi.org/10.1016/j.ophtha.2012.06.056 |
| Direitos |
2012, Elsevier |
| Palavras-Chave | #bevacizumab #ranibizumab |
| Tipo |
Journal Article |
